当前位置:首页 - 行情中心 - 永顺生物(920729) - 财务分析

永顺生物

(920729)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

永顺生物(920729)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.20亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益64962.66万元,未分配利润10827.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产76338.51万元,负债11375.86万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入121,726,217.0165,456,650.96268,985,086.87200,361,538.4
营业总成本105,146,428.2858,827,999.72233,726,259.2171,882,299.31
其他经营收益
营业利润21,973,532.748,718,430.1244,184,044.0732,416,644.51
利润总额21,932,915.028,711,054.0644,507,963.7232,528,900.59
净利润19,720,898.197,916,030.8240,143,422.4428,963,470.19
每股收益
其他综合收益----
综合收益总额19,720,898.197,916,030.8240,143,422.4428,963,470.19
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计580,319,845.74601,207,705.58564,818,676.77583,675,829.04
非流动资产:
非流动资产合计183,065,303.42187,802,993.87195,610,979.65204,126,306.84
资产总计763,385,149.16789,010,699.45760,429,656.42787,802,135.88
流动负债:
流动负债合计105,310,687.34109,176,068.8390,109,813.96129,359,533.08
非流动负债:
非流动负债合计8,447,891.199,083,350.759,690,609.549,483,967.29
负债合计113,758,578.53118,259,419.5899,800,423.5138,843,500.37
所有者权益(或股东权益):
归属于母公司股东权益合计649,626,570.63670,751,279.87660,629,232.92648,958,635.51
股东权益合计649,626,570.63670,751,279.87660,629,232.92648,958,635.51
负债和股东权益合计763,385,149.16789,010,699.45760,429,656.42787,802,135.88
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计131,062,431.3863,399,329.16274,807,406.03191,603,830.7
经营活动现金流出小计87,711,875.4146,336,875.46202,270,764.07136,288,060.22
经营活动产生的现金流量净额43,350,555.9717,062,453.772,536,641.9655,315,770.48
投资活动产生的现金流量:
投资活动现金流入小计227,812,633.19120,362,370.26346,420,391.85218,736,213.26
投资活动现金流出小计274,582,659.9167,040,357.9497,050,790.38377,314,452.34
投资活动产生的现金流量净额-46,770,026.71-46,677,987.64-150,630,398.53-158,578,239.08
筹资活动产生的现金流量:
筹资活动现金流入小计15,514,413.6215,514,413.6228,893,932.227,380,732.2
筹资活动现金流出小计35,854,706.28154,603.1475,456,982.249,481,106.48
筹资活动产生的现金流量净额-20,340,292.6615,359,810.48-46,563,050-22,100,374.28
汇率变动对现金及现金等价物的影响104,841.04133,736.22-44,808.91-249,972.09
现金及现金等价物净增加额-23,654,922.36-14,121,987.24-124,701,615.48-125,612,814.97
期末现金及现金等价物余额12,785,651.8222,318,586.9436,440,574.1835,529,374.69
补充资料:
现金及现金等价物的净增加额-23,654,922.36--124,701,615.48-
TOP↑